Company: BDRX
Filing Date: 2025-12-11
Form Type: F-1/A
Source: 0001214659-25-017944
Chunk: 3

Company: Biodexa Pharmaceuticals Plc
Filing Date: 2025-12-11
Form: F-1/A
Chunk 3
---
ii) two Series L Warrants. Subject to limited exceptions, a holder of Pre-Funded Warrants will not have the right to exercise any
portion of its Pre-Funded Warrants if the holder, together with its affiliates, would beneficially own in excess of 4.99% (or, at the
election of the holder, up to 9.99%) of the number of Ordinary Shares outstanding immediately after giving effect to such exercise. The
purchase price of each Pre-Funded Unit will be equal to the price per Unit being sold to the public in this offering, minus $0.0001,
and the exercise price of each Pre-Funded Warrant included in the Pre-Funded Unit will be $0.0001 per Depositary Share. The Pre-Funded
Warrants will be immediately exercisable (subject to the beneficial ownership cap) and may be exercised at any time until all of the
Pre-Funded Warrants are exercised in full.

The Depositary Shares and
Pre-Funded Warrants, and the accompanying Series L Warrants, as the case may be, can only be purchased together in this offering but will
be issued separately and will be immediately separable upon issuance. Pursuant to the registration statement related to this prospectus,
we are also registering the Depositary Shares issuable upon exercise of the Series L Warrants and Pre-Funded Warrants included in the
Units and Pre-Funded Units offered hereby.

For each Pre-Funded Unit
we sell (without regard to any limitation on exercise set forth therein), the number of Units we are offering will be decreased on a
one-for-one basis. Because the Series L Warrants are being sold together in this offering with each Depositary Share and, in the alternative,
each Pre-Funded Warrant to purchase one Depositary Share, the number of Series L Warrants sold in this offering will not change as a
result of a change in the mix of the Depositary Shares and Pre-Funded Warrants sold.

Our
Depositary Shares are listed on the NASDAQ Capital Market under the symbol “BDRX.” On December 10, 2025, the last
reported sale price of our Depositary Shares on the NASDAQ Capital Market was $6.72 per share. All Depositary Share, Pre-Funded
Warrant and Series L Warrant numbers are based on an assumed combined public offering price of $4.07 per Unit, which is based
upon the closing price of our Depositary Shares on